QT Vascular, losses widen 2015

FEB 29, 20168:19 PM

CATALIST-LISTED QT Vascular sank further into the red in FY2015, dragged by higher research and development (R&D) expenses, as well as a US$23.4 million recognised as damages the company had to fork out in relation to the AngioScore judgement.

For the full year, net loss leapt 55.2 per cent to US$53.1 million.

Read original article here:


Come, leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s